Image: Drug Discovery TrendsHow CTF is trying to rescue pharma’s shelved rare disease drugs
• Children’s Tumor Foundation (CTF) CEO Annette Bakker reports that over 5,000 potential treatments for rare diseases are currently shelved by pharmaceutical companies. • The organization is working to rescue these dormant drug candidates to provide options for patients with rare conditions who lack viable therapies. • This initiative addresses a critical gap in drug development where promising compounds are abandoned due to market size or corporate priorities.
drugdiscoverytrends.com


